Is ABBV Worth Buying in 2026?

ABBVIE INC.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-16

Here’s whether ABBVIE INC. (ABBV) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.68% over 10 days); RSI 41 — healthy momentum range; strong 1-year return of +21.9%; 3-month momentum positive (+18.6%). Currently 6.7% off its 52-week high. Score: +7/7.

Ready to act on this? 📈 Trade on Webull

ABBV is in a confirmed uptrend, trading above both its 50-day ($244.46) and 200-day ($225.61) moving averages. An RSI of 41.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +21.9% compares to +20.4% for SPY (beat the market by 1.5%).

$10,000 invested 1 year ago → $12,188 today
vs. S&P 500 (SPY) — same period beat market by 1.5%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($225.61)
Above 50-day MA ($244.46)
RSI(14) neutral zone (30–70) — currently 41.0
Positive return (+21.9%)
Within 10% of period high (−6.7%)
Period Range $249.46
$190.75 $267.47
RSI (14) 41.0
0 · OversoldOverbought · 100

Key Metrics

Price$249.46
Period Return+21.9%
Period High$267.47
Period Low$190.75
Drawdown−6.7%
MA-50$244.46
MA-200$225.61
RSI (14)41.0
Avg Volume (30d)5.7M
vs. SPYbeat by 1.5%
Return Rank#464 of 1252

Trade ABBV

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers